NEW FILINGS
Company: Keros Therapeutics, Inc.
Symbol: KROS
Description: They are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Jefferies, SVB Leerink, Piper Sandler
Co-Manager(s): HC Wainwright
Filed: 3-16-20
Listed Cash Raise: $86.25m
New Filings & Updated Terms: Week ending 3.20.20am
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish